PRODUCT LITERATURE
Therapeutic benefits of glutamine: An umbrella review of meta-analyses
Glutamine may be an essential amino acid in patients with catabolic disease, as it has been demonstrated that circulating glutamine levels drop during critical illness and following major surgery; this may result in an increase in secondary infection risk, recovery time and mortality rates. However, there is much discrepancy in the literature with regards to randomized controlled studies, and therefore, the present study is an umbrella review of published meta‑analyses, conducted to examine the effectiveness of glutamine's role as a therapeutic agent.
No other version available